Net profit of CARE Ratings rose 29.14% to Rs 35.90 crore in the quarter ended December 2025 as against Rs 27.80 crore during the previous quarter ended December 2024. Sales rose 16.33% to Rs 112.12 crore in the quarter ended December 2025 as against Rs 96.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales112.1296.38 16 OPM %35.9831.57 - PBDT52.6841.72 26 PBT48.9938.72 27 NP35.9027.80 29 Powered by Capital Market - Live News

CARE Ratings has allotted 3,500 equity shares under ESOS. The Paid-up Share Capital of the Company will accordingly increase from Rs. 30,04,18,630/- consisting of 3,00,41,863 equity shares of Rs. 10/- each to Rs. 30,04,53,630/- consisting of 3,00,45,363 equity shares of Rs.10/- each. Powered by Capital Market - Live News

CARE Ratings will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

CARE Rating has allotted 16,834 equity shares under ESOS on 09 January 2025. The paid-up share capital of the company will accordingly increase from Rs. 30,02,50,290/- consisting of 3,00,25,029 equity shares of Rs.10/- each to Rs.30,04,18,630/- consisting of 3,00,41,863 equity shares of Rs.10/- each. Powered by Capital Market - Live News

CARE Ratings announced that the Board of Directors of the Company at its meeting held on 12 November 2025, inter alia, have recommended the interim dividend of Rs 8 per equity Share (i.e. 80%) , subject to the approval of the shareholders.Powered by Capital Market - Live News